Literature DB >> 7712044

Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance.

M A Austin1, J E Hokanson, J D Brunzell.   

Abstract

Emerging evidence suggests that subclasses of LDL, characterized by variations in density, size, and chemical composition of LDL particles, are of important clinical significance. Accumulating case-control studies demonstrate that a predominance of small, dense LDL particles (LDL subclass phenotype B) is associated with an increased risk of coronary heart disease, and several potential atherogenic mechanisms have been proposed. New studies also demonstrate that LDL subclass phenotype B is an integral feature of the insulin resistance syndrome. In addition to the well-documented genetic influences on LDL subclass distributions, lipid-altering drugs, diet, and exercise all appear to affect LDL subclasses. A better understanding of this combination of genetic and environmental influences could lead to the development of effective intervention strategies for the prevention of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7712044     DOI: 10.1097/00041433-199412000-00002

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  23 in total

Review 1.  LDL particle size: an important drug target?

Authors:  I Rajman; P I Eacho; P J Chowienczyk; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  Three-dimensional structure of low density lipoproteins by electron cryomicroscopy.

Authors:  E V Orlova; M B Sherman; W Chiu; H Mowri; L C Smith; A M Gotto
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

3.  Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins.

Authors:  M A Austin; P J Talmud; L A Luong; L Haddad; I N Day; B Newman; K L Edwards; R M Krauss; S E Humphries
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

4.  Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease.

Authors:  G T Russo; A Giandalia; E L Romeo; M Marotta; A Alibrandi; C De Francesco; K V Horvath; B Asztalos; D Cucinotta
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

Review 5.  Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype.

Authors:  M A Austin
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

6.  Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency.

Authors:  J E Hokanson; J D Brunzell; G P Jarvik; E M Wijsman; M A Austin
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

7.  Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.

Authors:  J Q Purnell; S M Marcovina; J E Hokanson; H Kennedy; P A Cleary; M W Steffes; J D Brunzell
Journal:  Diabetes       Date:  1995-10       Impact factor: 9.461

8.  Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia.

Authors:  Marco Gentile; Ilenia Calcaterra; Alfonso Strazzullo; Carmen Pagano; Delia Pacioni; Enza Speranza; Paolo Rubba; Gennaro Marotta
Journal:  Clin Lipidol       Date:  2015-11-23

9.  Tracking and determinants of LDL particle size in healthy children from 7 to 11 years of age: the STRIP Study.

Authors:  Tuuli Kaitosaari; Olli Simell; Jorma Viikari; Olli Raitakari; Marja Siltala; Maarit Hakanen; Aila Leino; Eero Jokinen; Tapani Rönnemaa
Journal:  Eur J Pediatr       Date:  2008-07-05       Impact factor: 3.183

10.  Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene.

Authors:  Antonio López-Ruiz; María M Jarabo; María L Martínez-Triguero; Maria Morales-Suárez-Varela; Eva Solá; Celia Bañuls; Marta Casado; Antonio Hernández-Mijares
Journal:  Lipids Health Dis       Date:  2009-03-31       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.